Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Giunta

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Pharmaceutics|January 20, 2010
Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's diseaseAdam Smith, Brian Giunta, Paula C Bickford, et al.
Neural Plasticity|July 21, 2007
Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying testGabor Legradi, Mahasweta Das, Brian Giunta, et al.
Journal of Neuroinflammation|August 2, 2012
The immunology of traumatic brain injury: a prime target for Alzheimer's disease preventionBrian Giunta, Demian Obregon, Renuka Velisetty, et al.
Neuroscience Letters|January 26, 2010
Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 miceBrian Giunta, Houyan Hou, Yuyan Zhu, et al.
Journal of Neuroinflammation|November 19, 2008
Inflammaging as a prodrome to Alzheimer's diseaseBrian Giunta, Francisco Fernandez, William V Nikolic, et al.
Frontiers in Neurology|March 28, 2013
Microglia activation as a biomarker for traumatic brain injuryDiana G Hernandez-Ontiveros, Naoki Tajiri, Sandra Acosta, et al.
Critical Reviews in Neurobiology|May 5, 2009
Psychiatric implications of hepatitis-C infectionBrian Giunta, Charurut Somboonwit, William V Nikolic, et al.
Biochemical and Biophysical Research Communications|June 15, 2010
Rapamycin promotes beta-amyloid production via ADAM-10 inhibitionSheqing Zhang, Jon Salemi, Hauyan Hou, et al.
Technology and Innovation|September 22, 2012
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASEBrian Giunta, Juan Deng, Jingji Jin, et al.
Neuromolecular Medicine|June 15, 2017
Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in VitroHuayan Hou, Ahsan Habib, Dan Zi, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Pharmaceutics|January 20, 2010
Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's diseaseAdam Smith, Brian Giunta, Paula C Bickford, et al.
Neural Plasticity|July 21, 2007
Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying testGabor Legradi, Mahasweta Das, Brian Giunta, et al.
Journal of Neuroinflammation|August 2, 2012
The immunology of traumatic brain injury: a prime target for Alzheimer's disease preventionBrian Giunta, Demian Obregon, Renuka Velisetty, et al.
Neuroscience Letters|January 26, 2010
Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 miceBrian Giunta, Houyan Hou, Yuyan Zhu, et al.
Journal of Neuroinflammation|November 19, 2008
Inflammaging as a prodrome to Alzheimer's diseaseBrian Giunta, Francisco Fernandez, William V Nikolic, et al.
Frontiers in Neurology|March 28, 2013
Microglia activation as a biomarker for traumatic brain injuryDiana G Hernandez-Ontiveros, Naoki Tajiri, Sandra Acosta, et al.
Critical Reviews in Neurobiology|May 5, 2009
Psychiatric implications of hepatitis-C infectionBrian Giunta, Charurut Somboonwit, William V Nikolic, et al.
Biochemical and Biophysical Research Communications|June 15, 2010
Rapamycin promotes beta-amyloid production via ADAM-10 inhibitionSheqing Zhang, Jon Salemi, Hauyan Hou, et al.
Technology and Innovation|September 22, 2012
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASEBrian Giunta, Juan Deng, Jingji Jin, et al.
Neuromolecular Medicine|June 15, 2017
Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in VitroHuayan Hou, Ahsan Habib, Dan Zi, et al.
Pageof 6